Bioplatforms Australia Press Release
Vice-President Jo Biden announces Cancer Research MoU
Bioplatforms Australia (BPA) is a signatory to a Memorandum of Understanding (MoU) between researchers in the USA and Australia, announced by US Vice-President Joe Biden. The MoU will facilitate the sharing of an unprecedented international dataset which will significantly advance cancer research and care.
Bioplatforms Australia through the Australian Commonwealth Government NCRIS programme enables Australian researchers in the fields of Genomics, Proteomics, Metabolomics and Bioinformatics.
BPA General Manager Andrew Gilbert said, “We are at a juncture where the research
Specifically, this MoU will work on how to better define diseases of cancer patients, to assist clinicians to select the best therapies with the least side-effects. Not only will an improvement in patient outcomes with regard to morbidity and quality of life be expected, but there will be less impact on the cost of public health from this disease.
“Solving the cancer riddle is important to Australians,” said Gilbert. “BPA is working towards this holy grail through a high-quality collaborative approach. With the MoU we will see the best people working together locally, with international peers, to make a difference that would not be possible if pursued in silos.”
The signatories to the MoU are Bioplatforms Australia, Macquarie University, Garvan Institute of Medical Research and the Children’s Medical Research Institute in Australia, and The National Cancer Institute at the National Institutes of Health in the US. Researchers at these facilities will collaborate in the field of clinical proteogenomic studies and the subsequent translation to cancer care (
Andrew Gilbert | T: 02 9850 8281 | firstname.lastname@example.org